Search Within

Christina M Covington

Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Center for Pancreatic Cancer Research (8)
  2. Department of Medicine (8)
  3. Gastrointestinal Oncology Service (8)
  4. Solid Tumor Oncology Division (8)
  5. Epidemiology and Biostatistics (6)
  6. Biostatistics Service (4)

More Groups

People
  1. Eileen O'Reilly (8)
  2. Kenneth Yu (8)
  3. Maeve Lowery (7)
  4. Danielle Glassman (6)
  5. Ghassan Abou-Alfa (5)
  6. James Harding (5)

More People

Years
  1. 2018 (2)
  2. 2017 (3)
  3. 2016 (3)
Publications
  1. Journal of Clinical Oncology (4)
  2. BMC Cancer (1)
  3. Cancer (1)
  4. Cancers (1)
  5. Clinical Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (1)
  3. Biomed Central Ltd (1)
  4. MDPI (1)
  5. Wiley Blackwell (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor and invasive cell gene expression profile predicts treatment response and survival in pancreatic adenocarcinoma
    Journal Article

    Yu, K. H.; Ricigliano, M.; McCarthy, B.; Chou, J. F.; Capanu, M.; Cooper, B.; Bartlett, A.; Covington, C.; Lowery, M. A.; O’Reilly, E. M.
    Cancers (2018)

    Fulltext@MSK | Save
  • Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
    Journal Article

    Glassman, D. C.; Palmaira, R. L.; Covington, C. M.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • Phase IB trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in patients with advanced pancreatic cancer (PC)
    Meeting Abstract

    Lowery, M. A.; Harding, J. J.; Yu, K. H.; Kelsen, D. P.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; Yu, K. H.; Kelsen, D. P.; Harding, J. J.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Real-time genomic profiling of pancreatic ductal adenocarcinoma: Potential actionability and correlation with clinical phenotype
    Journal Article

    Lowery, M. A.; Jordan, E. J.; Basturk, O.; Ptashkin, R. N.; Zehir, A.; Berger, M. F.; Leach, T.; Herbst, B.; Askan, G.; Maynard, H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Breast cancer resistance protein (ABCG2) as a potential biomarker for gemcitabine and nab-paclitaxel sensitivity
    Meeting Abstract

    Yu, K. H.; Ricigliano, M.; O'Reilly, E. M.; Lowery, M. A.; Cooper, B.; Covington, C. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1B trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in subjects with advanced pancreatic cancer (APC)
    Meeting Abstract

    Lowery, M. A.; Capanu, M.; Glassman, D. C.; Covington, C. M.; Gluskin, J.; Brenner, R.; Li, C. F.; Bomalaski, J. S.; Johnston, A.; Barba, A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save